Madrigal Pharmaceuticals (MDGL) Insider Trading & Ownership $284.49 +1.03 (+0.36%) (As of 07/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Madrigal Pharmaceuticals (NASDAQ:MDGL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.92%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$43.38 MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$39.25 M Get MDGL Insider Trade Alerts Want to know when executives and insiders are buying or selling Madrigal Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MDGL Insider Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Madrigal Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2024Robert E WaltermireVPSell1,900$280.00$532,000.00 6/12/2024Robert E WaltermireVPSell2,000$285.00$570,000.00 5/21/2024Robert E WaltermireVPSell1,036$231.34$239,668.24 5/14/2024Fred B CravesDirectorSell22,489$212.88$4,787,458.32 4/8/2024Paul A FriedmanDirectorSell26,270$246.19$6,467,411.30 4/8/2024Rebecca TaubCMOSell2,676$245.99$658,269.24 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/5/2024Rebecca TaubCMOSell27,506$243.36$6,693,860.16 4/4/2024Paul A FriedmanDirectorSell18,710$242.96$4,545,781.60 4/3/2024Rebecca TaubCMOSell27,845$245.14$6,825,923.30 4/1/2024James M DalyDirectorSell32,489$102.77$3,338,894.53 4/1/2024Richard S LevyDirectorSell11,000$257.48$2,832,280.00 12/13/2023Bros. Advisors Lp BakerDirectorBuy81,159$219.39$17,805,473.01 12/13/2023Robert E WaltermireVPSell2,500$225.40$563,500.00 12/4/2023Brian Joseph LynchSVPSell1,800$218.87$393,966.00 11/29/2023Brian Joseph LynchSVPSell4,000$199.19$796,760.00 11/21/2023Bros. Advisors Lp BakerDirectorBuy64,350$188.47$12,128,044.50 11/17/2023Bros. Advisors Lp BakerDirectorBuy46,370$174.70$8,100,839.00 11/14/2023Bros. Advisors Lp BakerDirectorBuy34,188$156.42$5,347,686.96 (Data available from 1/1/2013 forward) MDGL Insider Trading Activity - Frequently Asked Questions Who is on Madrigal Pharmaceuticals's Insider Roster? The list of insiders at Madrigal Pharmaceuticals includes Brian Joseph Lynch, Bros. Advisors Lp Baker, Fred B Craves, James M Daly, Paul A Friedman, Rebecca Taub, Remy Sukhija, Richard S Levy, and Robert E Waltermire. Learn more on insiders at MDGL. What percentage of Madrigal Pharmaceuticals stock is owned by insiders? 23.92% of Madrigal Pharmaceuticals stock is owned by insiders. Learn more on MDGL's insider holdings. Which Madrigal Pharmaceuticals insiders have been buying company stock? The following insider purchased MDGL shares in the last 24 months: Bros. Advisors Lp Baker ($43,382,043.47). How much insider buying is happening at Madrigal Pharmaceuticals? Insiders have purchased a total of 226,067 MDGL shares in the last 24 months for a total of $43,382,043.47 bought. Which Madrigal Pharmaceuticals insiders have been selling company stock? The following insiders have sold MDGL shares in the last 24 months: Brian Joseph Lynch ($6,787,946.00), Fred B Craves ($4,787,458.32), James M Daly ($3,338,894.53), Paul A Friedman ($11,013,192.90), Rebecca Taub ($14,178,052.70), Remy Sukhija ($8,224,200.00), Richard S Levy ($9,424,930.35), and Robert E Waltermire ($1,905,168.24). How much insider selling is happening at Madrigal Pharmaceuticals? Insiders have sold a total of 254,710 Madrigal Pharmaceuticals shares in the last 24 months for a total of $59,659,843.04 sold. More Insider Trading Tools from MarketBeat Related Companies: Rocket Pharmaceuticals Insider Buying Y-mAbs Therapeutics Insider Buying Generation Bio Insider Buying BioMarin Pharmaceutical Insider Buying Neurocrine Biosciences Insider Buying United Therapeutics Insider Buying Incyte Insider Buying Exact Sciences Insider Buying Repligen Insider Buying Ionis Pharmaceuticals Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Selling: When It Matters and When It Doesn'tInsiders Sell These Tech Stocks, but Investors Shouldn’tWhat Does Market Rotation Mean for This Top AI Stock?3 Beaten Down Stocks That Insiders Are Buying3 Insider-Buy Stocks to Add to Your Watchlist Now This page (NASDAQ:MDGL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.